Ad
AGIO Quote Trading Chart Agios Pharmaceuticals Inc.
home / stock / agio / agio quote
$27.35 Last:
27.21% Change Percent:
$27.72 Open:
$21.50 Previous Close:
$28.89 High:
$27.14 Low:
76,795 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
AGIO Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-08-15 | 27.72 | 21.5 | 28.89 | 27.14 | 76,795 |
| 2022-08-12 | 26.32 | 21.5 | 28.63 | 26.16 | 823,175 |
| 2022-08-11 | 28.3 | 21.5 | 28.5 | 25.77 | 722,846 |
| 2022-08-10 | 28.12 | 21.5 | 28.39 | 27.15 | 683,581 |
| 2022-08-09 | 28.27 | 21.5 | 28.975 | 27.1 | 756,018 |
| 2022-08-08 | 29.5 | 21.5 | 29.59 | 28.265 | 672,686 |
| 2022-08-05 | 27.82 | 21.5 | 30.05 | 27.09 | 1,061,455 |
| 2022-08-04 | 25.57 | 21.5 | 28.62 | 25.57 | 1,164,676 |
| 2022-08-03 | 23.35 | 21.5 | 24.96 | 23.35 | 685,643 |
| 2022-08-02 | 21.13 | 21.5 | 23.26 | 21 | 902,443 |
| 2022-08-01 | 21.24 | 21.5 | 21.79 | 21.01 | 423,428 |
| 2022-07-29 | 21.38 | 21.5 | 21.609 | 20.9 | 785,900 |
| 2022-07-28 | 21.5 | 21.5 | 21.86 | 20.8924 | 564,596 |
| 2022-07-26 | 19.96 | 19.96 | 20.21 | 19.44 | 198,642 |
| 2022-07-25 | 20.51 | 20 | 20.86 | 19.81 | 426,376 |
| 2022-07-19 | 21.18 | 21.62 | 21.89 | 21.085 | 441,417 |
| 2022-07-18 | 22.81 | 20.98 | 23.0346 | 20.89 | 544,899 |
| 2022-07-15 | 23.1 | 22.31 | 23.18 | 21.73 | 850,272 |
| 2022-07-14 | 22.57 | 22.71 | 23.11 | 22.19 | 568,766 |
| 2022-07-13 | 23.29 | 22.66 | 24.14 | 22.61 | 813,915 |
Agios Pharmaceuticals Inc. Company Name:
AGIO Stock Symbol:
NASDAQ Market:
Agios Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
-
CAMBRIDGE, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism pioneering therapies for genetically defined diseases, today announced the appointments of Rahul Ballal, Ph.D., chief executive officer of Imara, and ...
-
– In Adults with Non-transfusion-dependent α- or β-Thalassemia, PYRUKYND ® Induced ≥1.0 g/dL Hemoglobin Increase from Baseline in 16 of 20 (80%) Patients Between Weeks 4-12 – – PYRUKYND ® Safety Profil...
-
Maraganore brings more than 35 years of scientific, research and development, capital markets and managerial leadership expertise to ProKidney Fox joins Board with more than 25 years of healthcare investment banking, finance and capital markets experience WINSTON-SALEM, N....